We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Microvast Soars 223% in a Year: How Should Investors Play the Stock?
Read MoreHide Full Article
Key Takeaways
Microvast's shares have skyrocketed over the year but have fallen sharply in the past month.
Huzhou Phase 3.2 aims to boost capacity, though supply chain issues pose risks.
Q3 results showed a net loss, led by a $12.6M non-cash fair value adjustment.
Microvast Holdings (MVST - Free Report) shares have experienced remarkable growth over the past year. It has surged 223.3% during the period, outperforming the 11% rise of its industry and 17.8% growth of the Zacks S&P 500 Composite.
MVST has outperformed its competitors, with GigaCloud Technology (GCT - Free Report) and Byrna Technologies (BYRN - Free Report) gaining 73% and 4%, respectively.
1-Year Share Price Performance
Image Source: Zacks Investment Research
However, the recent performance paints a different picture, with Microvast shares dipping 24.7% in the past month. Microvast has underperformed its industry peers, GigaCloud Technology and Byrna Technologies, over the past month. GigaCloud Technology and Byrna Technologies have rallied 18.7% and 7.8%, respectively.
Let us analyze further to find out whether investors should ride the rally or square off their position to book profits.
Huzhou Phase 3.2: Microvast’s Capacity Expansion
MVST’s APAC-centric Huzhou Phase 3.2 expansion is vital to expanding its production capacity. This project is expected to add 2 GWh in annual production capacity in the first quarter of 2026. The key priority of this plan is to cater to the strong customer demand, cementing Microvast’s path to capture a higher market share.
This expansion is supported by MVST’s prudent CapEx trend. In the third quarter of 2025, the company logged $17.4 million in CapEx, out of which $15.5 million was apportioned to the expansion plan. The company managed to shoulder $30.6 million in CapEx in the year-ago quarter, highlighting its focus on high-return capacity expansions rather than asset base building.
Despite this optimistic trajectory, Microvast may find itself amid operational execution risks. Supply-chain disruption may hinder equipment installation and commissioning for expansion by the year-end, deteriorating the scalability of capacity.
MVST’s Net Loss: What Triggered This Setback?
A net loss of $1.5 million in the third quarter of 2025 from the year-ago quarter’s net profit of $13.2 million signals instability in core profitability, raising red flags for investors. In the recently reported quarter, Microvast’s inability to generate profit despite registering 21.6% year-over-year growth in its revenues and a 440-basis-point expansion in the gross margin raises serious questions about the business model.
This fiasco is particularly due to a $12.6-million non-cash loss from changes in the fair value of warrant liability and convertible loan. It provokes questions on how a solid operational performance does not guarantee profitability due to unpredictable accounting adjustments of debt and equity.
Microvast’s Capital Return Trails Industry
Return on equity (ROE) is a profitability metric that assesses how effectively a company utilizes shareholders' equity to generate earnings. By the end of the third quarter of 2025, Microvast reported a ROE of 12.1%, below the industry’s 15.5%.
Image Source: Zacks Investment Research
Return on invested capital (ROIC) reveals a company’s efficacy in deploying total capital to generate operating profits. In the case of MVST, it stands at 6.3%, which is lower than the industry’s 7.7%.
Image Source: Zacks Investment Research
Lagging the industry in capital generation efficiency weakens MVST’s competitive advantage due to subpar profit generation from its equity and capital base compared with its peers.
MVST’s Alarming Liquidity Position
As of Sept. 9, 2025, Microvast held $143 million in cash and equivalents compared with a significantly higher $335 million current debt. It hints at liquidity risks and financial distress, further confirmed by its current ratio of 0.8 in the third quarter of 2025, which, aside from being below 1, also underperforms the industry’s 1.5. Taking everything into account, it appears that MVST may face challenges in settling its short-term obligations.
Image Source: Zacks Investment Research
Microvast’s Zero Dividend-Payout Policy
Neither MVST declared dividends nor disclosed any plans to do so in the near future. Therefore, the only way to achieve a return on investment in the company’s stock is share price appreciation, which is not guaranteed, evidenced by a 24.7% decline in its share price in the past month. Hence, dividend-seeking investors may find Microvast shares unappealing.
Sell MVST for Now
Despite a substantial decrease in the share price over the past month, Microvast has shown a massive upside of 233.3% in a year. Investors who have held on to this stock for the long run may consider selling their shares to book profits now, as we are highly skeptical regarding Microvast’s investment prospects.
Despite the company’s well-managed plan for Huzhou Phase 3.2 expansion, operational risks linger. The recent detriment in terms of net loss compared with a considerably profitable year-ago quarter raises red flags. Alongside this distress, MVST falls behind its industry in terms of capital return, affecting investors’ morale.
We have reservations about the company’s liquidity position as it hints at the inability to pay off short-term obligations. Microvast’s zero dividend policy makes dividend-seeking investors shy away from investing, which is another concern.
We expect these factors to lead to a further decrease in the share price. Hence, we recommend potential investors to stay away from this stock for now.
Microvast carries a Zacks Rank #4 (Sell) at present.
Image: Bigstock
Microvast Soars 223% in a Year: How Should Investors Play the Stock?
Key Takeaways
Microvast Holdings (MVST - Free Report) shares have experienced remarkable growth over the past year. It has surged 223.3% during the period, outperforming the 11% rise of its industry and 17.8% growth of the Zacks S&P 500 Composite.
MVST has outperformed its competitors, with GigaCloud Technology (GCT - Free Report) and Byrna Technologies (BYRN - Free Report) gaining 73% and 4%, respectively.
1-Year Share Price Performance
However, the recent performance paints a different picture, with Microvast shares dipping 24.7% in the past month. Microvast has underperformed its industry peers, GigaCloud Technology and Byrna Technologies, over the past month. GigaCloud Technology and Byrna Technologies have rallied 18.7% and 7.8%, respectively.
Let us analyze further to find out whether investors should ride the rally or square off their position to book profits.
Huzhou Phase 3.2: Microvast’s Capacity Expansion
MVST’s APAC-centric Huzhou Phase 3.2 expansion is vital to expanding its production capacity. This project is expected to add 2 GWh in annual production capacity in the first quarter of 2026. The key priority of this plan is to cater to the strong customer demand, cementing Microvast’s path to capture a higher market share.
This expansion is supported by MVST’s prudent CapEx trend. In the third quarter of 2025, the company logged $17.4 million in CapEx, out of which $15.5 million was apportioned to the expansion plan. The company managed to shoulder $30.6 million in CapEx in the year-ago quarter, highlighting its focus on high-return capacity expansions rather than asset base building.
Despite this optimistic trajectory, Microvast may find itself amid operational execution risks. Supply-chain disruption may hinder equipment installation and commissioning for expansion by the year-end, deteriorating the scalability of capacity.
MVST’s Net Loss: What Triggered This Setback?
A net loss of $1.5 million in the third quarter of 2025 from the year-ago quarter’s net profit of $13.2 million signals instability in core profitability, raising red flags for investors. In the recently reported quarter, Microvast’s inability to generate profit despite registering 21.6% year-over-year growth in its revenues and a 440-basis-point expansion in the gross margin raises serious questions about the business model.
This fiasco is particularly due to a $12.6-million non-cash loss from changes in the fair value of warrant liability and convertible loan. It provokes questions on how a solid operational performance does not guarantee profitability due to unpredictable accounting adjustments of debt and equity.
Microvast’s Capital Return Trails Industry
Return on equity (ROE) is a profitability metric that assesses how effectively a company utilizes shareholders' equity to generate earnings. By the end of the third quarter of 2025, Microvast reported a ROE of 12.1%, below the industry’s 15.5%.
Return on invested capital (ROIC) reveals a company’s efficacy in deploying total capital to generate operating profits. In the case of MVST, it stands at 6.3%, which is lower than the industry’s 7.7%.
Lagging the industry in capital generation efficiency weakens MVST’s competitive advantage due to subpar profit generation from its equity and capital base compared with its peers.
MVST’s Alarming Liquidity Position
As of Sept. 9, 2025, Microvast held $143 million in cash and equivalents compared with a significantly higher $335 million current debt. It hints at liquidity risks and financial distress, further confirmed by its current ratio of 0.8 in the third quarter of 2025, which, aside from being below 1, also underperforms the industry’s 1.5. Taking everything into account, it appears that MVST may face challenges in settling its short-term obligations.
Microvast’s Zero Dividend-Payout Policy
Neither MVST declared dividends nor disclosed any plans to do so in the near future. Therefore, the only way to achieve a return on investment in the company’s stock is share price appreciation, which is not guaranteed, evidenced by a 24.7% decline in its share price in the past month. Hence, dividend-seeking investors may find Microvast shares unappealing.
Sell MVST for Now
Despite a substantial decrease in the share price over the past month, Microvast has shown a massive upside of 233.3% in a year. Investors who have held on to this stock for the long run may consider selling their shares to book profits now, as we are highly skeptical regarding Microvast’s investment prospects.
Despite the company’s well-managed plan for Huzhou Phase 3.2 expansion, operational risks linger. The recent detriment in terms of net loss compared with a considerably profitable year-ago quarter raises red flags. Alongside this distress, MVST falls behind its industry in terms of capital return, affecting investors’ morale.
We have reservations about the company’s liquidity position as it hints at the inability to pay off short-term obligations. Microvast’s zero dividend policy makes dividend-seeking investors shy away from investing, which is another concern.
We expect these factors to lead to a further decrease in the share price. Hence, we recommend potential investors to stay away from this stock for now.
Microvast carries a Zacks Rank #4 (Sell) at present.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.